| Designer drugs 2015: assessment and management MF Weaver, JA Hopper, EW Gunderson Addiction science & clinical practice 10, 1-9, 2015 | 208 | 2015 |
| Bariatric surgery history among substance abuse treatment patients: prevalence and associated features KK Saules, A Wiedemann, V Ivezaj, JA Hopper, J Foster-Hartsfield, ... Surgery for obesity and related diseases 6 (6), 615-621, 2010 | 135 | 2010 |
| Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives JA Hopper, MW Speece, JL Musial Journal of general internal medicine 12 (10), 639-642, 1997 | 100 | 1997 |
| A randomized trial of computer-delivered brief intervention and low-intensity contingency management for smoking during pregnancy SJ Ondersma, DS Svikis, PK Lam, VS Connors-Burge, DM Ledgerwood, ... Nicotine & tobacco research 14 (3), 351-360, 2012 | 92 | 2012 |
| Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans MK Greenwald, KJ Schuh, JA Hopper, CR Schuster, CE Johanson Psychopharmacology 160, 344-352, 2002 | 71 | 2002 |
| Abuse liability assessment of sibutramine, a novel weight control agent LM Schuh, CR Schuster, JA Hopper, CM Mendel Psychopharmacology 147, 339-346, 2000 | 68 | 2000 |
| Environmental tobacco smoke exposure among urban children JA Hopper, KA Craig Pediatrics 106 (4), e47-e47, 2000 | 67 | 2000 |
| Injection drug use in North America EP Schoener, JA Hopper, JD Pierre Infectious Disease Clinics 16 (3), 535-551, 2002 | 49 | 2002 |
| Prescription drug use and abuse: Risk factors, red flags, and prevention strategies JH Isaacson, JA Hopper, DP Alford, T Parran Postgraduate medicine 118 (1), 19-26, 2005 | 43 | 2005 |
| Management of the hospitalized injection drug user JA Hopper, T Shafi Infectious Disease Clinics 16 (3), 571-587, 2002 | 36 | 2002 |
| Injection drug use and wound care B Pieper, JA Hopper Nursing Clinics 40 (2), 349-363, 2005 | 30 | 2005 |
| Reducing opioid misuse among adolescents through physician education NS Arora, KM Marcotte, JA Hopper Substance Abuse 39 (1), 6-8, 2018 | 11 | 2018 |
| Tobacco cessation: new challenges, new opportunities JA Hopper, RE Gallagher Journal of Cancer Education 18 (3), 128-133, 2003 | 10 | 2003 |
| A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence JA Hopper, J Wu, W Martus, JD Pierre Journal of Opioid Management 1 (1), 31-35, 2005 | 9 | 2005 |
| Substance use trajectories of post-bariatric surgery patients enrolled in substance abuse treatment A Wiedemann, KK Saules, J Hopper, J Foster-Hartsfield, V Ivezaj, ... Poster presentation at the annual meeting of the Society for Behavioral …, 2010 | 5 | 2010 |
| A multifactorial intervention for hospital opioid management. M Akce, A Suneja, C Genord, B Singal, JA Hopper Journal of Opioid Management 10 (5), 337-344, 2014 | 4 | 2014 |
| P-33: Why are post-bariatric patients in substance abuse treatment? Patients' perceptions of etiology and future recommendations V Ivezaj, K Saules, A Wiedemann, DW Wood, JA Hopper, A Eshelman Surgery for Obesity and Related Diseases 6 (3), S38-S39, 2010 | 2 | 2010 |
| Revising the Treatment Plan and/or Ending Addiction Treatment JA HOPPER, TV PARRAN JR The American Society of Addiction Medicine Handbook on Pain and Addiction, 268, 2018 | | 2018 |
| POST-BARIATRIC SURGERY PATIENTS VERSUS CONTROLS IN SUBSTANCE ABUSE TREATMENT KK Saules, D Schwarz, JA Hopper, J Foster-Hartsfield, A Wiedemann, ... ANNALS OF BEHAVIORAL MEDICINE 39, 196-196, 2010 | | 2010 |
